Cita APA

Jahnsen, J. (2016). Clinical experience with infliximab biosimilar Remsima (CT-P13) in inflammatory bowel disease patients. Therap Adv Gastroenterol.

Chicago Style Citation

Jahnsen, Jørgen. "Clinical Experience With Infliximab Biosimilar Remsima (CT-P13) in Inflammatory Bowel Disease Patients." Therap Adv Gastroenterol 2016.

Cita MLA

Jahnsen, Jørgen. "Clinical Experience With Infliximab Biosimilar Remsima (CT-P13) in Inflammatory Bowel Disease Patients." Therap Adv Gastroenterol 2016.

Atenció: Aquestes cites poden no estar 100% correctes.